Agalsidase Beta vs Trastuzumab

## Agalsidase Beta vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Agalsidase Beta** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Agalsidase Beta — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Agalsidase Beta — Enzyme; Trastuzumab — Antibody.